Objective and design: Iodide concentration (IC) in salt was cautiously increased in Switzerland (15-20 ppm iodide). We evaluated the dynamics of the effect of this intervention on urinary iodine concentration (UIC, mg/l) and on thyroid parameters. Setting: University Hospital in Bern, Switzerland. Subjects: A cohort of 36 subjects (12 children, 11 women, 13 men) out of 44 were recruited. Interventions: During the study periods PRE (May 1996-May 1998 and POST (October 1998-December 2000, subdivided into equal subperiods POST1 and POST2), that is, before and after the increase of IC in salt, subjects collected 6248 urine spots for analysis of UIC. Thyroid volumes (n ¼ 2/subject) and serum thyroid parameters (n ¼ 8/subject) were sequentially evaluated. Methods: Average PRE-POST data were compared (multiple regression analysis). Results: UIC increased overall by 5.1% (P ¼ 0.0003). Increase of UIC was highest in children (11.3%, Po0.0001), significant in women (8%, P ¼ 0.0016), but not significant in men (P ¼ 0.143). Comparison between periods POST1 and POST2 showed that UIC changed more gradually in women than in children. Thyroid volumes were normal, no nonphysiological change occurred. TSH indicated euthyroidism; it decreased in children (1.98 ) 1.74 mU/l, P ¼ 0.04) and increased in men (1.65 ) 1.91mU/l, P ¼ 0.025). FT3 decreased in children (Po0.004) and FT4 decreased in men (P ¼ 0.017), both within normal ranges. TSH, FT3 and FT4 were unchanged in women. FT3/FT4 ratios were stable. Anti-TPO-Ab titers were stable (P ¼ 0.9). Anti-Tg-Ab titers decreased (P ¼ 0.009). Conclusion: The significant UIC effects were of uncertain metabolic relevance. No pathological side effects occurred. Differential delays and penetrances of UIC increase in children and adults were hitherto unknown. The unspectacular stepwise policy seems to be safe. Our pilot results in a population with moderate iodine deficiency in women should be confirmed in population-based cluster studies.
Introduction
Micronutrient deficiency is an underlying cause of morbidity and mortality in the world, deserving highest attention (Black, 2003) . Correcting iodine deficiency (ID) in particular, especially in the event of exposure to radioactive iodine, is such a sound investment in both health and social development (Sternthal et al, 1980; Report ETA, 1985; Tiwari et al, 1996; Van den Briel et al, 2000; Als et al, 2002; Black, 2003) that 'yin medical history, iodine prophylaxis has an unsurpassed cost-benefit advantagey' (David Marine, Chicago, 1920s) . In populations with severe ID, reversibility of profound hypothyroidism could indeed be obtained with as little as a single injection of iodized oil, even at low doses (Tonglet et al, 1992) . Alternatively, effective programs worldwide have made iodized salt available. The rationale of iodine fortification of iodine-deficient populations is nowadays unquestioned, as it has proven to be a highly cost-effective measure for the prevention of iodine deficiency disorders (IDD) and as substantial progress towards its elimination has already been made (de Benoist and Clugston, 2002; Black, 2003; Sebotsa et al, 2003) .
The actual debate goes towards fine tuning of specific public health interventions, mostly by iodized salt. Theoretically, severe ID may be corrected rapidly in a one-step intervention, by promoting an iodide concentration (IC) in salt, considered 'curative' and definitive, right from the beginning of the intervention (Jooste et al, 2001) . Alternatively, ID may be corrected progressively, by consecutive steps over several years or decades, that is, by stepwise increases of IC in salt, as has been the case in Switzerland (Als et al, 2003a) . The former policy has the undeniable advantage of a rapid decrease of the frequency and severity of goiter, hypothyroidism and other IDD. However, due to a high or rapidly increased iodine supply, functional, autoimmune or other thyroidal side effects may appear (Stanbury et al, 1998) . As only little experimental data are available concerning the stepwise policy, it is unclear whether lesser secondary thyroidal effects would result from a cautious, progressive increase of iodine supply, especially in case the studied population does not present severe ID, but rather mild or moderate ID.
The cautious and progressive Swiss model of supplying iodine by salt for the prevention of IDD has no equivalent.
Severe ID had prevailed up to the 1920s. Salt was slightly iodized (3.75 ppm iodide) as early as in 1922. Thereafter, IC in salt was progressively increased in 1965 (7.5 ppm iodide) and in 1980 (15 ppm iodide). In order to further reduce incidence of IDD such as small goiters occurring during pregnancy and transient neonatal hypothyroidism associated with borderline ID in women in the reproductive age (Als et al, 2000a; Brander et al, 2003) , IC in salt was again increased from 15 to 20 ppm (or from 20 to 25 mg potassium iodide/kg salt) by ministerial decree in 1998 in Switzerland. The reason why the 1998 increase of IC in salt was rather small was that negative secondary effects were to be avoided and thereby political acceptance increased (Ermans et al, 1995; Bourdoux et al, 1996; WHO, 1997; Stanbury et al, 1998) .
Recommended dietary allowance of iodine is 150 mg/day (children and adults). Urinary iodine concentration (UIC) represents a good approximation of iodine supply; median UIC ought to be 4100 mg/l (Delange, 1998) . Former examples of hidden sources of iodine excess, of significant and unexpected modifications of UIC in a population after an intervention on IC in salt or after a change in the consumption of iodized vs noniodized salt point to the importance of performing prospective studies (Ermans et al, 1995; WHO, 1997; Delange, 1998; Zhao et al, 1998; Bürgi et al, 1999; Als et al, 2000a, b; Black, 2003; Brander et al, 2003) . Thus, UIC in the NHANES III survey in the US showed an unexpectedly important decrease of UIC between the 1971-1974 and 1988-1994 periods, probably due to a decreased use of iodate as bread stabilizer (Hollowell et al, 1998) .
In this regard, sequential evaluations of UIC, of thyroid volume and of serum thyroid parameters provide sensitive markers of the effect of a modified iodine supply. The aim of this prospective longitudinal cohort study was to document UIC, thyroid volume and serum parameters before and after a cautious interventional measure of public health in a population presenting mild ID in age-and genderdependent subgroups (Als et al, 1995a (Als et al, , 2000a . Primary questions addressed were: Would an increment of IC in salt by only 5 ppm or by 33% lead to a significant increase of UIC in children and adults? Would variable dynamics of a UIC effect in children and in adults be revealed? Would a sonographic change of thyroid volume be observed? Would metabolic or auto-immune signs of increased or decreased thyroid gland stimulation be observed? Which parameters would represent the most sensitive follow-up tools for thyroid alterations?
Materials and methods
Iodized salt and its effects in Switzerland Production and trade of iodized and uniodized salt are organized by state monopoly. The estimated cost of salt iodization is low, about $50 000/y. In all, 55-60% of the salt sold in Switzerland is iodized, 30% is half-iodized for industrial purposes and 10-15% is uniodized. It is, however, unknown how much salt is consumed nationwide and how much is exported or used for winter salting. Due to iodized salt, former severe ID in Switzerland seemed resolved in the 1980s when a sufficient UIC of 141 mg/day was found in 112 adults from all over Switzerland (Bürgi et al, 1990) . In the 1990s, however, median UIC was again found moderately deficient: 70-90 mg/l in adult volunteers (n ¼ 266, aged 436 y and n ¼ 54, aged 19-75 y) (Als et al, 1995a (Als et al, , 2000a . Confirming Marine's statement, the clinical effects of iodized salt were impressive. Endemic cretinism had disappeared and frequency of anaplastic thyroid carcinoma had decreased with as little as 3.75 ppm iodide in salt. Endemic goiter had become less frequent and severe with every increase of IC in salt (Bürgi et al, 1990) . Last not least, and as opposed to reports from other parts of the world (Bourdoux et al, 1996; Stanbury et al, 1998) ; no 'epidemic' of iodineinduced hyperthyroidism occurred after the 1980 increase of IC in salt in Switzerland, as indicated by stable rates of hyperthyroidism in referral hospitals in Bern and Solothurn (Als et al, 1995b; Bürgi et al, 1998) .
Study periods PRE and POST
The prospective study protocol was approved by the Ethical Commission of the University of Bern and supported by the 'Swiss National Foundation for Scientific Research' (grant number 32-49424.96 ). Increase of IC in salt from 15 to 20 ppm iodide, initially scheduled for January 1997, took place only in September 1998 for political reasons, because it was at that time considered of lesser priority than other -prionic, infectious or noxious -health problems (Als et al, 2000a, b) . Due to this delay, known only after the start of the study, sampling duration, initially planned for about 2 y, and intervals of blood tests had to be adapted. The full study period 1996-2000 was subdivided into sampling periods PRE (before the increase of IC in salt, from May 1996 to May 1998, that is, 424 months) and POST (after the increase, from midOctober 1998 to mid-December 2000, that is, 26 months) with a pause of about 6 months in between (May to mid-October 1998). As salt delivery from production site to the home table is supposed to take 3-6 months, the 'new' salt was thought to reach the consumer during winter 1998-1999 or spring 1999. Thereafter, the duration of the followup phase of period POST still exceeded 18 months, estimated to be sufficiently long for observing potential effects. In order to evaluate the dynamics of the effect of UIC, period POST was subdivided into equal 13-month subperiods POST1 and POST2 (first and second years of period POST, respectively).
Subjects
Out of 44 recruited healthy volunteer Bernese subjects (friends of the first author), 36 (11 households, five with children) completed the study, that is, 12 children (aged 3-15 y in May 1996, median 7 y, 5 girls, 7 boys), 11 women (aged 30-65 y, median 40 y) and 13 men (aged 25-74 y, median 51 y). In view of consistency with regional goiter epidemiology, two men under L-T 4 supplementation since a hemi-thyroidectomy for benign goiter 20 and 5 y before, respectively, were included. The cohort was thereby more representative of the regional population (Bürgi et al, 1990) . For personal reasons ('ytoo complicated, not interested.'), 14 persons had refused to participate as study subjects right from the beginning. As because of the cited political reasons study duration by far outlasted the initial commitment, there were eight dropouts. Thus, out of the 44 subjects who had participated initially, only those 36 participating in both PRE and POST sampling periods were considered. Subjects signed an informed consent; parents signed for their children. None of the female subjects became pregnant. No subject had an intercurrent relevant disease nor a change in the -adequate -socio-economic status during the study period.
Nutrition
Subjects continued their usual diets. None was on a medical or vegetarian diet. No dietary instructions, particularly on consumption of iodized salt, were given. Subjects were, however, known to consume iodized salt. Compared to foodstuffs prepared individually at home with iodized salt, intake of industrially processed foodstuffs, conditioned with uniodized or half-iodized salt, does not seem to account for an increased iodine supply in Switzerland. Owing to participation in the study, subjects were more interested in matters of iodine supply than the general population. Two male subjects had a somewhat 'silent iodine prophylaxis' based on periodic intake of preparations based on vitamins and oligoelements (75 mg I/day). None consumed or took baths with sea-weed.
Sampling of spot urines
The 36 subjects collected 6254 spot urine samples (2-5 samples/person/month, at any time of the day, as convenient). Urines were immediately frozen (À201C). Owing to iodine exposure due to radiological contrast media, 6 samples were excluded (UIC range: 4 293-36 566 mg/l). Thus, a total of 6248 spot urine samples (100%) were left for statistical evaluation (Table 1) .
Laboratory analyses of urinary iodine (in lg I/l) They were performed in two continuous run-throughs (PRE: May-September 1998 and POST: June-December 2000) in the SFOPH laboratory. Urinary iodine was measured using inductively coupled plasma mass spectrometry (ICP-MS); the inherent CV of the method is 2.5% (Haldimann et al, 1998) . Isotope dilution analysis using 129 I as a spike was applied (Haldimann et al, 1998) . A quality control sample containing the major urinary matrix components urea (18 g/l) and sodium chloride (3 g/l) with an iodine concentration of 80 mg/l was analyzed in every series. The mean difference between target and measured value was À0.1 mg/l (RSD 4%, n ¼ 86).
Sampling of biochemical thyroid parameters
Between April 1996 and January 2001, thyroid functional and immunologic parameters were evaluated with blood tests of thyreostimuline (TSH), free thyroxine (FT4), free triiodothyronine (FT3), thyroid anti-peroxidase (anti-TPOAb) and anti-thyroglobulin antibodies (anti-Tg-Ab), (n ¼ 8/ subject, Division of Clinical Chemistry, Inselspital).
Laboratory analyses of serum thyroid parameters Quality control was realized by including certified samples in all analytical series. The manufacturer's instructions were followed. All normal ranges are given in Table 2 . Up to July 1999, TSH, FT3 and FT4 were evaluated by chemoluminescence immunoassay (Bayer ACS:180, CH-Zürich). As of August 1, 1999, for organizational reasons, the laboratory switched to enzyme immunoassay for 44 remaining samples of TSH, FT4 and FT3 (Abbott Axsym, CH-Baar, identical normal ranges, except minor, irrelevant differences). Assay comparison showed a good agreement following Passing and Bablok regression (regression for TSH:
In order to adapt to the assay switch, we calculated 'adjusted' or 'chemoluminescence-like' values of TSH, FT4 and FT3 for the 44 serum samples concerned, based on regressions of data measured by enzyme immuno assay. Anti-TPO-Ab and anti-Tg-Ab were evaluated by enzyme immunoassay over the whole study period (Pharmacia Synelisa, Pharmacia & Upjohn, CHDübendorf).
Sonography
Ultrasonographic thyroid gland morphology and volumetry (longitudinal Â sagittal Â transverse axes/lobe, divided by 2) were assessed before (March-April 1996) and after (January- The present UIC results of period PRE are numerically comparable with those from an area-covering random sample of 412 volunteers from the same region, the Canton of Bern, of homogenous gender groups and of seven distinct age groups, who had been contacted by random digit dialing and had collected urine spots between March and May 1997, that is, during period PRE (Als et al, 2000a) . It therefore appears that the present UIC results from a limited sample of subjects may be considered representative of the regional population.
February 2001) the study period (Department of Radiology, Inselspital).
Data management and statistical analyses
Statistical analyses were carried out using the SAS program, mainly the module Insight (SAS system 8.02, SAS Institute, Cary NC, USA) employing multiple regression analysis. To evaluate increase of UIC in period POST, multiple regression analysis takes the form of
where I is the logarithm of UIC (log UIC, mg/l), P 0 denotes the log UIC level of the reference person, b denotes the (unknown) change of I ( ¼ log UIC) between periods PRE and POST, T denotes periods PRE and POST (PRE ¼ 0 and POST ¼ 1), P i denotes the difference of person i to the reference person, e i denotes the unexplained part. This model adapts to every subject their own log UIC level, thus reducing the variability and improving fit. The coefficient b measures the average difference of log UIC between periods PRE and POST. Residual analysis was performed by generating normal probability plots, which indicated near normality after log transformation. In addition to analyzing all data, separate multiple regression analyses were performed for children, women and men. In this model, tests on effects correspond to tests on differences in median values of UIC. A similar model, without log transformation, was applied to analyze changes of the thyroid volumes per proband group between periods PRE and POST. To search for a potential UIC increase early or rather gradually during period POST, UIC of equal 13 months subperiods POST1 and POST2 (first and second years of period POST, respectively) were evaluated separately. Improvement of fit over the basic PRE-POST model was thereafter tested using an F-test. A similar model as with UIC, based on multiple regression analysis, but without log transformation, was applied to analyze changes in average values of TSH, FT3, FT4, the FT3/FT4 ratio, anti-TPO-Ab and anti-Tg-Ab titers between periods PRE and POST. 
Results

UIC
Overall median UIC was found to be above 100 mg/l in children and men, but not in women. Table 1 and Figure 1 summarize UIC results. There was a significant (Po0.0003) increase of UIC by an estimated average of 5.1% between periods PRE and POST in all 36 subjects (n ¼ 6248 samples). However, when children, women and men were considered separately, UIC response varied. UIC increase was most pronounced in children (11.3%, Po0.0001), followed by women (8%, P ¼ 0.0016), whereas with men there was no significant increase (P ¼ 0.143).
For the complete data set, there was evidence for a gradual UIC increase, as shown by comparing UIC of periods PRE and of subperiods POST1 and POST2 (F-test: 4.12, df: 1 and 6207, Po0.025). The onset of UIC effect was deferred in women (Ftest: 5.65, df: 1 and 2102, P ¼ 0.0175), but was not deferred in children (F-test: 0.042, df: 1 and 1978, ns) . Men showed no UIC increase in either model (Figure 1 ).
Sonography
Thyroid volumes (Table 1) were normal in children and adults, except in a man with a pre-existing, volumetrically stable goiter. Thyroid volume was stable in women (P ¼ 0.7) and men (P ¼ 0.25) and increased age-dependently in children from 2.2 to 4.7 ml (Po0.0001). No echostructural anomalies occurred, not even in the men with partial thyroidectomy.
Hormones
All data were found within the physiological (euthyroid) range, except one single TSH value. Average TSH decreased slightly in children (from 1.98 to 1.74 mU/l, P ¼ 0.04), increased in men (from 1.65 to 1.91 mU/l, P ¼ 0.025) and was stable in women (Table 2 ). All single TSH values indicated euthyroidism (range 0.7-3.6 mU/l in children, 0.7-3.9 mU/l in women, 0.7-4.3 mU/l in men) with one exception. Indeed, one latent hypothyroid TSH value of 4.7 mU/l in a woman with both positive antibody titers at the beginning of the study was found at 2 mU/l 6 months later, that is, in the euthyroid range, while antibody titers had decreased. Average FT3 decreased in children (Po0.004) and was stable in adults. Average FT4 decreased in men (P ¼ 0.017) and remained stable in children and in women (ns). Average FT3/FT4 ratios were stable.
Auto-antibodies
In children and men, average auto-antibody titers were found negative in periods PRE and POST (Table 3A) . In women, average titers of both auto-antibodies were found mildly positive in period PRE; anti-TPO-Ab titers remained mildly positive in period POST while anti-Tg-Ab titers had become negative in period POST. In three women at the beginning of the study in particular, we found increased anti-TPO-Ab (range 239-618 U/ml) and/or anti-Tg-Ab titers (range 74-1118 U/ml). At the study end, we found a decrease down to (near-)normal values in two women and an increase (anti-Tg-Ab from 618 up to 1110 U/ml) in one woman only.
In the global data set, average titers did not increase from periods PRE to POST. Instead, a significant decrease of average anti-Tg-Ab titer occurred in the subject group as a whole (P ¼ 0.009) and more especially in men (P ¼ 0.007) (Table 3A) . In other words, average anti-TPO-Ab titers were more stable than were average anti-Tg-Ab titers. In all subjects, no directional change of average titers per indivi- Figure 1 Moving average of UIC of an exemplary child (a), woman (b) and man (c) over the study period, illustrating statistically highly significant early (a) or gradual (b) and absent (c) increases of UIC, respectively, after an increase by 5 ppm (33%) in the iodine content of salt. The expected, highly significant seasonal fluctuations of UIC in the child (a) are even more apparent (Als et al, 2003a) than the effect of the discussed public health intervention. Table 3 Comparison of auto-antibody titers in 36 healthy subjects in study periods PRE and POST with: (A) average a /range b auto-antibody titers per subject group; (B) % of all subjects with a change (positive2negative) of average auto-antibody titers Auto-antibodies (all normal ranges 0-60 U/ml) 
Positive titer: 460 U/ml, negative titer: r60 U/ml, type of change'': k: from positive to negative titer , m: from negative to positive titer, 2: no change in titer, PRE and POST: before and after increase of dual and especially no increase of average anti-TPO-Ab (P ¼ 1) nor of anti-Tg-Ab (P ¼ 0.09) titers per subject occurred from period PRE to period POST (Table 3B) . Per subject, from period PRE to period POST, the percentage of decreasing average anti-Tg-Ab titers was nonsignificantly higher than the percentage of increasing titers (Table 3B) .
Discussion
UIC
The public health intervention was targeted at an iodinesufficient population presenting mild ID in subgroups only, as for instance in young women (Als et al, 1995a (Als et al, , 2000a . In our opinion and for the sake of these subgroups, the fourth cautious increase of IC in salt by 33% in 1998 in Switzerland was justified, even if the effect was not as spectacular as, based on scarce literature data, had been expected. Over 2 y, we observed a small but statistically significant increase of UIC in children and women without an abnormal evolution in their thyroid data. Health relevance of the UIC effect is, however, as yet uncertain; moderate ID in women does not seem to be resolved. In Figure 1a , the UIC effect is visually less prominent than the highly significant seasonal fluctuations of UIC in an exemplary case of a 'milk-drinking' child, that consumed 0.8 l fresh milk/day. This seasonal effect had anyway been expected (Als et al, 2003a) . Due to higher iodine content in winter than in summer milk indeed, UIC in 'milk drinkers' has been found to be higher in winter than in summer (Als et al, 2003a) . Of course, in temperate climates the seasonal effect of UIC is proportional to the consumption of fresh milk. In virtually all other countries, absolute increases of IC in salt have been much higher than in Switzerland, by steps exceeding 10-20 ppm iodide. Although the initial introduction of iodized salt in Denmark, where mild to moderate ID prevailed, had been planned as a cautious, low-level increase of IC in salt by as little as 2 ppm iodide (Rasmussen et al, 1996) , it was finally implemented with 8 ppm iodide as of 1998 and with 13 ppm iodide as of the year 2000, in bread and in kitchen salt, but not in industrial salt (personal e-mail communication). Thus, only exceptional literature data deal with the effects of small nationwide increases of IC in salt (r5 ppm iodide); they concern severely iodine-deficient populations. In Switzerland in 1922, for instance, urinary iodine excretion was extremely low, only 18 mg/day in the village of Kaisten, before salt was for the first time iodized by 3.75 ppm iodide (Bürgi et al, 1990) . The effect, evaluated only decades later, showed an UIC of 60 mg/g creatinine in 1960 (Bürgi et al, 1990) . In 1998 in Switzerland, that is, in the present study period, however, the target populations were as well iodine-sufficient children as mildly iodine-deficient young women in the reproductive age and as elderly people (Als et al, 2000a) . This difference in baseline iodine supply between the target populations at the beginning and at the end of the XXth century in Switzerland most probably explains why the UIC effect in the present 1996-2000 study (5.1%) was less spectacular than after the 1922 intervention (about 300%) (Bürgi et al, 1990) . Caution is, however, warranted in comparing data expressed in different entities, as in a temperate climate UIC expressed as I/l or as I/ creatinine gives lower values than the gold standard I/day. The three measures should hence no longer be considered as identical (Als et al, 2003b) .
Owing to the longitudinal cohort study design -a complement to standard cluster protocols (WHO, 2001) -new aspects of UIC effects appear. The hitherto unknown differential delays and penetrance of UIC increases after an intervention on IC in salt need further investigation. A more rapid metabolic turnover, a larger volume of distribution per kg body weight and relatively higher dietary intakes per kg body weight in children than in women -both sharing meals at the family table -might explain a more rapid UIC increase, that is, adaptation to the 'new' iodine supply, in children. As UIC in children is known to decrease with age, from pre-school to school age children and to adolescents (Als et al, 2000a) , the present findings of an increased UIC in children in period POST can neither be considered an age effect. Moreover, milk is an important provider of iodine in Switzerland, as in other regions of the Northern hemisphere, especially in winter (Pennington, 1990; Sieber et al, 1999; Rasmussen et al, 2002; Als et al, 2003a,) . Therefore, abundant milk intake by children, as well as 'hidden' sources of iodine/ iodized salt within snacks and in-between dishes consumed in variable amounts following age-and gender-specific preferences, might in part explain higher UIC data in children (Als et al, 2003a) . The latter fact is not specific of Swiss diet. Indeed, higher UIC data in schoolchildren than in adults -and especially in women -have been documented elsewhere after introduction of iodized salt. Thus, a median UIC of 121 mg/l in 847 schoolchildren aged 8-10 y, compared to only 55 mg/l in 343 women after delivery, was found in Italy (Rapa et al, 1999) . Likewise, median UIC was 140 mg/l in 60 schoolchildren aged 11-17 y, compared to only 68 mg/l in 111 women at delivery in Tanzania (Sundqvist et al, 1998) . However, UIC during the third trimenon or after delivery is generally lower than in non-pregnant women of the same age (Glinoer et al, 1995; Brander et al, 2003) . As concerns UIC data in men in the present study, did a potential UIC increase occur later, after the end of our observation period? Is salt consumption less consistent and universal as previously supposed (Dunn 1992) ? It would be interesting to clarify these points by further studies.
Sonography
No nonphysiologic increase of thyroid volume was observed. Thus, doubling of thyroid volume over 4 y in our children subjects was an expected age effect (Bürgi et al, 1999 , Zimmermann et al, 2001 . Moreover, in the two men with a previously operated goiter, no goiter recurrence was registered during follow-up. The decreasing tendency (not significant) of average thyroid volume in men (Table 2 shows median values) is probably irrelevant. Manual volume determinations are indeed lacking absolute reproducibility.
Hormones
In this pilot cohort study, we found subtle changes in the levels of FT3, FT4 and TSH without any increase of anti-TPOAb and anti-Tg-Ab titers after 2 y. The findings in children (decrease of FT3 and of TSH with an increase of UIC by 11.3%) were different from those in men (decrease of FT4 and increase of TSH with no UIC change), while women showed no hormonal changes at all with an increase of UIC by 8%. Interpretation of these pilot results ought to be dependent on age and gender and on population-based cluster studies.
During childhood and adolescence, metabolic turnover of iodine, FT3 and FT4 as well as half-time of plasma disappearance of thyroxine are increased compared to adult life (Delange and Ermans, 1967; Malvaux, 1985) . As a consequence of agerelated metabolic adaptations, the concentrations of both FT4 and FT3 decrease gradually during childhood and maintain a plateau during adolescence (Fisher, 1996) . Our findings in children might therefore be explained by an age-related effect. This argument is supported by the stable FT3 values found in our adult subjects.
On this basis, the cautious rise of IC in salt by only 5 ppm or 33% showed no spectacular metabolic effect in the investigated subjects and did as well not induce functional or autoimmune pathologies. With women, even if UIC increased by 8%, mild ID does not seem to have been resolved and the metabolic effect of the intervention was irrelevant. In contrast to these unspectacular Swiss findings after a slight increase of the IC in salt, the efficiency of low oral doses of iodized oil had been more spectacular in populations presenting severe ID, as for instance in Zaire, where IDD was found corrected for a duration of about 1 y and no auto-immune side effects occurred (Tonglet et al, 1992) . In analogy, the introduction of lowly iodized salt in Switzerland in 1922 (3.75 ppm) aimed at a population with severe ID, had highly spectacular UIC and clinical effects (Bürgi et al, 1990) .
Thyroid hormone synthesis was recently reviewed by Taurog (1996) . Before the era of sensitive FT3 assays, it was known that fluctuations in iodine supply are compensated by inversely proportional fluctuations in TSH secretion (Studer et al, 1974) . It was then shown that feeding iodinedeficient diets to rats induced depletion of thyroidal iodine, thyroid enlargement, decrease in serum T4, increase in serum TSH, decrease in the deiodination of thyroglobulin, increase in thyroidal mono-iodo-thyrosin/di-iodo-thyrosin and T3/T4 ratios (Riesco et al, 1977) . In a longitudinal study conducted during human pregnancy, progressively decreasing UIC data in response to an insufficient, increasingly inadequate iodine supply led to increasing FT3/FT4 or T3/T4 ratios, TSH titers and thyroid volumes (Glinoer et al, 1995) . Moreover, in randomized groups of pregnant women, treated with potassium iodide (KI) alone or with KI plus L-T 4 , the T3/T4 ratio and TSH levels significantly decreased (Glinoer et al, 1995) . In those therapeutic trials, decreased TSH values and FT3/FT4 ratios most probably signaled reduced metabolic thyroid 'stress' or want in response to adequately increased iodine supplies. Translated to our pilot study, a decrease of TSH in our mildly iodine-deficient young women might have been observed, if the intervention had been metabolically effective, which apparently was not the case.
Based on TSH titers, no thyroidal dysfunction (that might tentatively have been linked to increased iodine supply) was observed in our 36 subjects during period POST. Contrarily to period PRE, there are no published data available yet on frequencies of hypo-and hyperthyroidism in the general Swiss population during period POST (Als et al, 1995b; Bürgi et al, 1998) . The absence of relevant TSH effects in our subjects after an only 33% increase of IC in salt contrast with data from elsewhere, where increments in IC of salt to populations with severe ID had been incomparably higher, by single-step interventions. Those massive increments, from conditions of severe ID (o30 mg I/day overall) up to 100-200 ppm iodide in salt (Stanbury et al, 1998) elicited notable side effects, such as iodine-induced hyperthyroidism, sometimes with lethal outcome (Todd et al, 1995; Bourdoux et al, 1996; Stanbury et al, 1998) . In Zimbabwe, for instance, the introduction of iodized salt to a population with severe ID resulted in an increase over 18 months in the incidence of iodine-induced hyperthyroidism, from 3/ 100 000 to 7/100 000 inhabitants (Todd et al, 1995) . Higher frequencies of iodine-induced hyperthyroidism were also found in Turkish adolescents and in the Zairian, formerly severely iodine-deficient population (Bourdoux et al, 1996; Emral et al, 2002) . In hot or tropical climates, where the stability of iodized salt is more difficult to achieve, insufficient quality management programs of salt conditioning and storage might play an unfavorable role, as the entire iodide content of a salt package may concentrate in the bottom of the sack. In general, symptoms of iodine-induced hyperthyroidism appear 1-18 months after the first use of the 'new' iodized salt (Stanbury et al, 1998) . In our study, sampling period POST ended more than 18 months after introduction of the 'new' salt. Thus, dysfunctions would most likely have been discovered on the basis of the thyroid parameters investigated within that period.
Auto-antibodies
Auto-antibody titers were found to be highest in women (average, range and percentage of titers above the normal limit, Table 3 ). Thus, subclinical auto-immune thyroiditis seems to have been more frequent in women than in men and in children. Our favorable findings, however -no rise of average antibody titers and no rise of the percentage of titers found above the normal limit, but rather a decrease of all anti-Tg-Ab titers -contrast with data from elsewhere, where the increment in iodine supply had been steeper. Experimentally, the steep rise of iodine supply in genetically susceptible mice caused a higher occurrence of autoimmune thyroiditis and of positive anti-Tg-Ab titers in a dosedependent manner after only 8 weeks (Rose et al, 1997) . In Sri Lanka, the prevalence of anti-Tg-Ab was found markedly raised (14.3-69.7%) in 367 schoolgirls aged 11-16 y, after commercial salt had been iodized at a variable degree in 1993 (Premawardhana et al, 2000) . In Turkish adolescents, the single-step introduction of highly iodized salt led to higher frequencies of positive titers of anti-TPO-Ab and anti-Tg-Ab (Emral et al, 2002) . Likewise, the introduction of iodized salt in Zaire in 1992 caused increases of positive anti-TPO-Ab (17%) and of anti-Tg-Ab (4%) titers in adults (Bourdoux and Mahangaiko-Lembo, 2002) . It is noteworthy that basic iodine supply of the cited populations from the literature was much lower than ours and that comparison must therefore be cautious.
In conclusion, the fourth cautious increase of IC in Swiss salt from 15 to 20 ppm, aimed at a population presenting borderline ID in age and gender-dependent subgroups only (Als et al, 2000a) , was politically well accepted. In a pilot cohort and within 2 y, the intervention had effects of an uncertain metabolic efficiency:
1. a moderate, lesser than expected, yet statistically significant increase of UIC; 2. no increase in thyroid volumes; 3. subtle changes of FT3, FT4 and of TSH that might be agerelated in children; 4. no increase of thyroid auto-antibodies.
As the problem of borderline ID in young women in the reproductive age does not yet seem to be resolved, a further step of cautious increase of IC in salt might be discussed in Switzerland. It is as yet unclear which thyroid parameter is the most sensitive marker of subclinical metabolic thyroidal effects, in addition to UIC. For future correction programs of severe or moderate ID at population level, gradual steps of increase of IC in salt, as in the Swiss experience, with an excellent cost-benefit relation, respecting the 'nil nocere' principle (Stanbury et al, 1998) might serve as arguments for stepwise rather than one-time increases of prophylactic iodine supply. Based on experience from the literature, the stepwise policy of iodine supply should lead to spectacular effects in a population with severe ID and to rather unspectacular effects in a population with moderate ID. Such prophylactic programs should ideally be accompanied by adequate studies including evaluation of TSH, FT3, FT4 and the FT3/FT4 ratio, thus allowing comparison between populations of different nutritional statuses.
